Check-Cap Ltd. (NASDAQ:CHEK) Short Interest Update

Check-Cap Ltd. (NASDAQ:CHEK) was the target of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 152,800 shares, a decrease of 36.9% from the February 28th total of 242,000 shares. Based on an average trading volume of 1,360,000 shares, the days-to-cover ratio is currently 0.1 days. Approximately 3.5% of the company’s shares are short sold.

Check-Cap Trading Down 6.1 %

Shares of CHEK stock traded down $0.05 on Friday, reaching $0.79. 15,652 shares of the company’s stock were exchanged, compared to its average volume of 366,541. The company’s fifty day simple moving average is $0.90 and its 200 day simple moving average is $1.09. The stock has a market capitalization of $4.62 million, a PE ratio of -0.26 and a beta of 0.19. Check-Cap has a 52 week low of $0.56 and a 52 week high of $3.10.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on shares of Check-Cap in a report on Tuesday, March 25th. They set a “sell” rating on the stock.

Check-Cap Company Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.